Hans Clevers

Hans Clevers

Hubrecht Institute, Utrecht, The Netherlands

Organoids as models of human cancer

John Dick

John Dick

Princess Margaret Cancer Centre, University of Toronto, Canada

Tracking the arc of AML and B-ALL from the cell of origin to the origin of relapse in a single blood sample

Sir Mike Stratton

Sir Mike Stratton

Wellcome Sanger Institute, Cambridge, UK

Signatures of mutational processes in human cancer

Mohamed Bentires-Alj

Mohamed Bentires-Alj

University of Basel, Switzerland

Breast tumor heterogeneity and metastasis: Act locally, think globally

Cédric Blanpain

Cédric Blanpain

Université Libre de Bruxelles, Belgium

Identifying the cells of origin in skin cancer

Daniel deCavalho

Daniel deCavalho

University of Toronto, Canada

Translation Aspects of DNA Methylation in Cancer

Peter Dirks

Peter Dirks

University of Toronto,
Canada

Florian Greten

Florian Greten

University of Frankfurt, Germany

Cell plasticity in stemness and tumor progression

Meritxell Hutch

Meritxell Hutch

The Gurdon Institute, University of Cambridge, UK

Liver organoids for the study of liver biology and disease

Sten-Erik Jacobsen

Sten-Erik Jacobsen

Karolinska Institutet, Sweden

Unravelling lineage potentials and fates of normal and leukemic stem and
progenitor cells

Maria Kasper

Maria Kasper

Karolinska Institutet, Sweden

Decoding skin cancer formation via niche modulation and single-cell transcriptomics

Carla Kim

Carla Kim

Harvard Medical School, Boston, USA

Regulation of progenitor cells in the adult lung and in lung cancer

Sean Morrison

Sean Morrison

University of Texas Southwestern, Dallas, USA

The metabolic regulation of cancer progression

Tomi Mäkelä

Tomi Mäkelä

Helsinki University, Finland

The role of LKB1 as a tumor suppressor and maintenance of intestinal stem cells

Kristian Pietras

Kristian Pietras

Lund University, Lund, Sweden

Microenvironmental control of the malignant phenotype in breast cancer

Toshiro Sato

Toshiro Sato

Keio University School of Medicine, Tokyo, Japan

4D-imaging of human colorectal cancer stem cells using organoid technology

Charles Sawyers

Charles Sawyers

Memorial Sloan Kettering Cancer Center, New York, USA

Lineage plasticity in prostate cancer

David Scadden

David Scadden

Harvard University, Boston, USA

Jeff Settleman

Jeff Settleman

Calico Life Science, San Francisco, USA

Reversible states of resistance to anti-cancer drugs

Michael Shen

Michael Shen

Columbia University Medical Center, New York, USA

Investigating bladder cancer using patient-derived tumor organoids

Liran Shlush

Liran Shlush

 Weizmann Institute of Science, Israel
Jessica Strid

Jessica Strid

Imperial College London, London, UK

A role for the IgE-FcεRI axis in tumour immune-surveillance

Mario Suvà

Mario Suvà

Harvard Medical School, Boston, USA

An integrative model of cellular states and genetics for glioblastoma

Charles Swanton

Charles Swanton

The Francis Crick Institute, London, UK

Chromosomal order and chaos: Cancer evolution and immune evasion.

Andreas Trumpp

Andreas Trumpp

Deutsches Krebsforschungszentrum, Heidelberg, Germany

Stem cells features in cancer

Thomas Würdinger

Thomas Würdinger

University Medical Center, Amsterdam, The Netherlands

Tumor-educated platelets for the detection of cancer

Leonard Zon

Leonard Zon

Harvard University, Boston, USA

Cancer initiation in zebrafish

Hosted by

Important dates

The application is now open!

Applications for participation in the Key 16 Origin of Cancer conference are welcome until February 17th, 2019
Please see the registration page for further details.

Professional Conference Organizer

For general information (registration, travel,
logistics etc.) kindly contact: key16@akademikonferens.se

Akademikonferens Direct +46 18 67 10 34 Switchboard +46 18 67 10 03

For scientific content (Conference application, program etc.) kindly contact: stratcan@ki.se